Fungal co-infection in COVID-19 patients: evidence from a systematic review and meta-analysis
Open Access
- 19 March 2021
- journal article
- research article
- Published by Impact Journals, LLC in Aging
- Vol. 13 (6), 7745-7757
- https://doi.org/10.18632/aging.202742
Abstract
Coronavirus disease 2019 (COVID-19) has infected tens of millions of people worldwide within the last year. However, the incidence of fungal co-infection in COVID-19 patients remains unclear. To investigate the association between fungal co-infection and mortality due to COVID-19, we systematically searched Medline, Embase, MedRxiv and Cochrane Library for eligible studies published in the period from 1 January to 1 December 2020. We performed a meta-analysis of nine studies that met the inclusion criteria. In total, data from 2780 patients and 426 patients were included who were admitted to the ICU. In eight of the articles, 211 participants died due to COVID-19 infection, which means an overall mortality rate of 10.9%. The overall pooled proportion of fungal co-infection in COVID-19 patients was 0.12 (95% CI = 0.07-0.16, n = 2780, I-2 = 96.8%). In terms of mortality in COVID-19 patients with fungal infection, the overall pooled proportion of mortality was 0.17 (95% CI = 0.10-0.24, n = 1944, I-2 = 95.6%). These findings provide evidence suggesting a favorable use for empirical antibiotics in the majority of patients when COVID-19 infection is diagnosed. Our analysis is investigating the use of antifungal therapy to treat COVID-19 can serve as a comprehensive reference for COVID-19 treatment.Keywords
This publication has 24 references indexed in Scilit:
- Alterations in Gut Microbiota of Patients With COVID-19 During Time of HospitalizationGastroenterology, 2020
- Co-infections in people with COVID-19: a systematic review and meta-analysisJournal of Infection, 2020
- Co-infection with respiratory pathogens among COVID-2019 casesVirus Research, 2020
- Bacterial and Fungal Coinfection in Individuals With Coronavirus: A Rapid Review To Support COVID-19 Antimicrobial PrescribingClinical Infectious Diseases, 2020
- Clinical characteristics of COVID-19 infection in chronic obstructive pulmonary disease: a multicenter, retrospective, observational studyJournal of Thoracic Disease, 2020
- Eleven faces of coronavirus disease 2019Allergy, 2020
- Clinical Features of 69 Cases With Coronavirus Disease 2019 in Wuhan, ChinaClinical Infectious Diseases, 2020
- Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational studyThe Lancet Respiratory Medicine, 2020
- Polymorphisms in Protamine 1 and Protamine 2 predict the risk of male infertility: a meta-analysisScientific Reports, 2015